We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Livanova | LSE:LIVN | London | Ordinary Share | GB00BYMT0J19 | ORD GBP1.00 (DI) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 50.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Jul 2019 to Jul 2024
LivaNova PLC (NASDAQ: LIVN; LSE: LIVN) (“LivaNova” or the “Company”), a market-leading medical technology and innovation company, today announced Damien McDonald, incoming Chief Executive Officer of LivaNova, and Vivid Sehgal, Chief Financial Officer of LivaNova, will both participate in discussions at the Jefferies London Healthcare Conference in London on Wednesday, November 16, 2016 and the Piper Jaffray Healthcare Conference in New York City on Tuesday, November 29, 2016.
The discussion at the Jefferies Healthcare Conference is scheduled to begin at 8:00 a.m. Greenwich Mean Time on Wednesday, November 16, 2016 and the discussion at the Piper Jaffray Healthcare Conference is scheduled to begin at 11:00 a.m. Eastern Standard Time on Tuesday, November 29, 2016. Both discussions will be available to all interested parties through a live audiocast accessible via the investor relations section of LivaNova's website at www.livanova.com. Listeners should log on approximately 10 minutes in advance to ensure proper setup to receive the audiocast. A replay of the webcast will be available on the LivaNova website approximately 24 hours after the live presentation for 90 days after the event.
About LivaNova
LivaNova PLC is a global medical technology company formed by the merger of Sorin S.p.A, a leader in the treatment of cardiovascular diseases, and Cyberonics Inc., a medical device company with core expertise in neuromodulation. LivaNova transforms medical innovation into meaningful solutions for the benefit of patients, healthcare professionals, and healthcare systems. The Company employs approximately 4,600 employees worldwide and is headquartered in London, U.K.
For more information, please visit www.livanova.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161111005631/en/
Investor Relations and MediaLivaNova PLCKaren King, +1 (281) 228-7262Vice President, Investor Relations & Corporate CommunicationsFax: +1 (281) 218-9332corporate.communications@livanova.com
1 Year Livanova Chart |
1 Month Livanova Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
